Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study on the Efficacy and Safety of Uronext® in Parallel Groups in Women With Cystitis in the Acute Stage

NCT05945667 is registered in ClinicalTrials.gov with PharmaLinea Ltd. as lead sponsor.

NCT NCT05945667
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05945667 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study on the Efficacy and Safety of Uronext® in Parallel Groups in Women With Cystitis in the Acute Stage
Lead sponsor
PharmaLinea Ltd.
Phase
Not applicable
Overall status
Completed
Start date
June 7, 2021
Completion date
February 28, 2022
Enrollment
111 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cystitis